José de Sá Moraes Neto

Dr. José de Sá Moraes Neto


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2025 in Journal of Thoracic Disease
Verified
Journal Article
Open access
PDF file
JNJosé de Sá Moraes Neto
José de Sá Moraes Neto
JFJaqueline Schaparini Fonini
Jaqueline Schaparini Fonini
FNFrancisco de Assis Cavalcanti Neto
Francisco de Assis Cavalcanti Neto
FOFernanda Aquino de Oliveira
Fernanda Aquino de Oliveira
ACAndre nathan Costa
Andre nathan Costa
Alessandro MarianiAlessandro Mariani
Alessandro Mariani
Background: Pulmonary architectural destruction often leads to significant clinical manifestations, including productive cough, recurrent infections, and hemoptysis, which may range from mild to life-threatening. This study aimed to compare perioperative outcomes between patients with non-massive and massive hemoptysis undergoing surgical resection for hemoptysis secondary to inflammatory/infectious lung diseases with pulmonary parenchymal destruction and to evaluate the impact of preoperative bronchial artery embolization (BAE) in those with massive hemoptysis. Methods: A retrospective analysis was conducted on patients treated between 2019 and 2024. Patients were categorized into two groups based on hemoptysis severity. A subgroup analysis was performed among those with massive hemoptysis, comparing outcomes between patients who underwent preoperative BAE and those who did not. All patients were followed up for 1 year. Exclusion criteria included incomplete records and loss to follow-up. Results: Fifty-one patients were included (mean age 42 years, 57% female). Non-massive hemoptysis was observed in 32 patients: 19 presented with massive hemoptysis. Among the latter, 8 underwent preoperative BAE. Massive hemoptysis was associated with increased need for transfusion (P=0.046) and prolonged intensive care unit (ICU) stay (P=0.02). In the embolization subgroup, patients without BAE had significantly longer pleural drainage (P=0.01), greater intraoperative blood loss (P=0.050), longer ICU stay (P=0.02), and higher transfusion rates (P=0.03). Conclusions: Massive hemoptysis is associated with greater perioperative morbidity. Preoperative BAE appears to be a beneficial and safe adjunct, improving surgical outcomes by reducing bleeding, transfusion needs, and ICU length of stay.

7 May 2025 in Journal of Surgery
Verified
Journal Article
Open access
PDF file
JNJosé de Sá Moraes Neto
José de Sá Moraes Neto
JFJaqueline Schaparini Fonini
Jaqueline Schaparini Fonini
AMAlessandro Wasum Mariani
Alessandro Wasum Mariani
PFPaulo Manuel Pego Fernandes
Paulo Manuel Pego Fernandes
The development of Video-Assisted Thoracoscopic Surgery (VATS) for the treatment of thymic disorders has led to reduced hospital stays, decreased post

1 November 2025 in Journal of Visualized Surgery
Verified
Journal Article
Open access
PDF file
JNJosé de Sá Moraes Neto
José de Sá Moraes Neto
MSMurilo Fernandes de Souza
Murilo Fernandes de Souza
PPPaulo Manuel Pêgo-Fernandes
Paulo Manuel Pêgo-Fernandes
AMAlessandro Mariani
Alessandro Mariani
Bronchopleural fistula (BPF) is a rare but severe complication following pneumonectomy, associated with high morbidity and mortality, particularly when pleural contamination occurs. Several predisposing factors have been described, including preoperative corticosteroid use, right-sided pneumonectomy, neoadjuvant therapy, diabetes mellitus, and the presence of a long bronchial stump. Preventive strategies such as bronchial stump reinforcement have been widely employed, though the optimal technique and material remain controversial. Therapeutic options range from minimally invasive approaches, including endobronchial closure with cauterization or biological glue, to complex surgical procedures such as intrathoracic muscle transposition, thoracostomy, and thoracoplasty. In cases where conventional reclosure of the stump is hindered by infection or adhesions, the transsternal transpericardial approach described by Abruzzini in 1961 offers an alternative that avoids direct manipulation of the infected pleural cavity. This technique enables safe exposure of the mediastinal structures through a full median sternotomy, allowing direct closure of the bronchial stump. The present study provides a descriptive account and educational video of the Abruzzini technique, based on a real clinical case. The patient, a 72-year-old male with silicosis and endobronchial aspergilloma, underwent left pneumonectomy with radical mediastinal lymphadenectomy. Postoperative evolution was complicated by stump dehiscence and recurrent BPF, despite previous surgical attempts with manual suturing and thymic flap reinforcement. Definitive management was achieved through the transsternal transpericardial approach, involving careful mediastinal dissection, protection of major vascular structures, and closure of the bronchial stump with stapling under bronchoscopic guidance. This report emphasizes the technical nuances of the procedure, including the impact of mediastinal shift in left pneumonectomy, the risks of vascular injury, and the necessity of meticulous preoperative imaging. Differences between left- and right-sided fistulas are also highlighted, underscoring the importance of individualized surgical planning. BPF remains one of the most challenging post-pneumonectomy complications, with mortality exceeding 50% in uncontrolled cases. Although rarely performed, the Abruzzini technique remains a valuable tool in selected scenarios, with reported success rates above 80%. By documenting this surgical approach through video demonstration, the present work aims to enhance thoracic surgery training, preserve classical techniques, and promote safer management of complex BPF.

24 June 2024 in Einstein (São Paulo)
Verified
Journal Article
Open access
PDF file
JNJosé de Sá Moraes Neto
José de Sá Moraes Neto
FQFlavia Alves Corrêa de Queiroz
Flavia Alves Corrêa de Queiroz
ICIsabele Alves Chirichela
Isabele Alves Chirichela
EREserval Rocha
Eserval Rocha
RTRicardo Mingarini Terra
Ricardo Mingarini Terra
PPPaulo Manuel Pêgo-Fernandes
Paulo Manuel Pêgo-Fernandes
Category: Robotic Technology in Thoracic Diseases Introduction: Colorectal cancer (CRC) is the leading cause of cancer death worldwide.() It is estimated that about 50% of patients with CRC develop metastasis during follow-up, most commonly in the liver followed by the lung. Lung metastasis is seen in approximately 10 – 15% of patients diagnosed with CRC.(,) Pulmonary metastasectomy is the treatment with the best survival rate.() Due to the high incidence of lung recurrence, in approximately 50% of cases, parenchyma-sparing lung

7 August 2025 in Frontiers in Neurology
Verified
Journal Article
Open access
PDF file
JNJosé de Sá Moraes Neto
José de Sá Moraes Neto
JFJaqueline Schaparini Fonini
Jaqueline Schaparini Fonini
FNFrancisco De Assis Cavalcanti Neto
Francisco De Assis Cavalcanti Neto
FOFernanda Aquino De Oliveira
Fernanda Aquino De Oliveira
GAGabriel Lunardi Aranha
Gabriel Lunardi Aranha
AMAlessandro Wasum Mariani
Alessandro Wasum Mariani
Objective: To evaluate a 10-year experience in the surgical treatment of patients with myasthenia gravis, focusing on clinical and pharmacological outcomes.Methods: A retrospective single-center study was conducted based on prospective data collection from the Redcap® maintained by the Thoracic Surgery Department in a Brazilian tertiary hospital. Patients with myasthenia gravis (AchR positive), who underwent surgical treatment as an adjuvant to clinical therapy were included.Results: The study comprised 85 patients with a mean age of 43 years; 75% were female. Regarding the type of surgery, 24.7% underwent sternotomy and 75.3% minimally invasive approach. The median hospital stay was 4.0 days (p25 = 3.0; p75 = 5.5), and the median ICU stay was 1.0 days (p25 = 0.40, p75 = 2). Postoperative outcomes showed a corticosteroid reduction in 52 participants (61%), and 30 (35%) showed anticholinesterase reduction. The median dose of corticosteroids before surgery was 40.00 mg, and after surgery, 20.00 (p-value < 0.001). Based on Osserman classification, before surgery, it was observed that 4% had grade I, 15% grade IIa, 32% grade IIb, 31% grade III, and 18% grade IV. After surgery, it was observed that 28.5% were asymptomatic, 28% had grade I, 34% had grade IIa, 3.6% had grade IIb, and 5.9% had grade III. There was no statistical difference in clinical and pharmacological response in the analysis with and without thymoma and myasthenia (p-value 0.403; p-value 0.104). About the surgical approach, patients undergoing thymectomy by sternotomy have longer hospital and ICU stays with statistical significance (p-value <0.001; p-value 0.005).Conclusion: This study demonstrated that surgical treatment for myasthenia gravis is safe and effective for symptom control and medication reduction, regardless of the surgical approach, with shorter ICU and hospital stays through the minimally invasive approach.

24 June 2024 in Einstein (São Paulo)
Verified
Journal Article
Open access
PDF file
FQFlavia Alves Corrêa de Queiroz
Flavia Alves Corrêa de Queiroz
JNJosé de Sá Moraes Neto
José de Sá Moraes Neto
CPCasimira Edeneia Lourenço Pedro
Casimira Edeneia Lourenço Pedro
JSJuliana Vieira de Oliveira Salerno
Juliana Vieira de Oliveira Salerno
JFJaqueline Schaparini Fonini
Jaqueline Schaparini Fonini
PPPaulo Manuel Pêgo-Fernandes
Paulo Manuel Pêgo-Fernandes
Category: Thoracic Oncology Introduction: Primary tracheal tumors have a prevalence around 0.2% of the entire respiratory system.() Two-thirds of tracheal tumors are malignant, of which 75% are squamous cell carcinoma and 15% are adenoid cystic carcinoma. Due to the low incidence, we chose to report the case of a patient with adenoid cystic carcinoma approached via videothoracoscopy and sternotomy with incomplete resection of the lesion (R1) with clinical and radiological control of the disease following adjuvant therapy.() Case video Summary: